Education
About Us
Working with TipRanks
Follow Us
Andrew Von-Eschenbach Insider Profile
4 Followers
Andrew Von-Eschenbach, Director at Bausch Health Companies, holds 40.05K shares in Bausch + Lomb Corporation (Ticker: BLCO), holds 336.07K shares in Celularity (Ticker: CELU), holds 0.00 shares in Radius Health (Ticker: ~RDUS).
Andrew Von-Eschenbach Bausch Health Companies (BHC)Director
Bausch Health Companies (BHC)
Director
Ranked #48,482 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+2.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Andrew Von-Eschenbach's holdings
Insider Roles
Roles that Andrew Von-Eschenbach holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 11, 2020 - Mar 11, 2021
Return:+86.30%
The most profitable trade made by Andrew Von-Eschenbach
Andrew Von-Eschenbach's Trading History
Bausch Health Companies
Aug 09, 2021
Director
Informative Buy
36.32K
$276.33K
Celularity
Jun 16, 2023
Director
Uninformative Buy
―
$413.36K
Radius Health
Aug 15, 2022
―
Uninformative Sell
55.00K
$0.00
Bausch + Lomb Corporation
Aug 06, 2024
Director
Uninformative Buy
―
$644.85K
TriSalus Life Sciences
―
Director
―
―
Lineage Therap
Aug 14, 2013
Director
Informative Buy
11.07K
$1.57K
Asterias Biotherapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Andrew Von-Eschenbach's performance on stock
You May Also Like
Andrew Von-Eschenbach insider profile FAQ
What is the percentage of profitable transactions made by Andrew Von-Eschenbach?
The percentage of profitable transactions made by Andrew Von-Eschenbach is 50%.
What is the average return per transaction made by Andrew Von-Eschenbach?
The average return per transaction made by Andrew Von-Eschenbach is 2.60%.
What stocks does Andrew Von-Eschenbach hold?
Andrew Von-Eschenbach holds: BHC, CELU, ~RDUS, BLCO, TLSI, LCTX, AST stocks.
What was Andrew Von-Eschenbach’s latest transaction?
Andrew Von-Eschenbach latest transaction was an Uninformative Buy of ―.
What was Andrew Von-Eschenbach's most profitable transaction?
Andrew Von-Eschenbach’s most profitable transaction was an Informative Buy of BHC stock on March 11, 2020. The return on the trade was 86.30%.
What is Andrew Von-Eschenbach's role in Bausch Health Companies?
Andrew Von-Eschenbach's role in Bausch Health Companies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.